Background illustration for clinical trials search

Paid Clinical Trials Olathe

Discover 707 paid clinical trials in Olathe, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 707

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for

Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,

Location: Kansas City KS, St Louis MO, Little Rock AR,

Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase2, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for

AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),

Location: Westwood KS, Birmingham AL, Houston TX, Detroit MI,

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase2, Recruiting

To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

for

Stroke, Walking, Difficulty, Cardiovascular Injury

Location: Kansas City KS

Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06247553

Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

for

Systemic Sclerosis, Scleroderma, Interstitial Lung Diseases

Location: Kansas City KS, Rochester MN, Chicago IL, Ann Arbor MI,

Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 70+

Code: NCT06328777

Phase2, Phase3, Recruiting

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

for

Primary Myelofibrosis

Location: Kansas City KS, St Louis MO, Cincinnati OH,

Sponsor: Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06343805

Phase1, Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

for

Systemic Lupus Erythematosus, Lupus Nephritis

Location: Kansas City KS, Minneapolis MN, Chicago IL, Houston TX,

Sponsor: Cabaletta Bio

Sex: All

Age: 18 - 65

Code: NCT06121297

Phase1, Phase2, Recruiting

Mitigating the Pro-inflammatory Phenotype of Obesity

for

Blood Pressure, Diabetes, Obesity, Insulin Resistance,

Location: Kansas City KS

Sponsor: University of Kansas Medical Center

Sex: All

Age: 18 - 70+

Code: NCT04934228

Phase1, Recruiting

Abatacept in Immune Checkpoint Inhibitor Myocarditis

for

Myocarditis Acute, Cancer

Location: Kansas City KS, Rochester MN, Chicago IL, Dallas TX,

Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT05335928

Phase3, Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

for

Metastatic Hepatocellular Carcinoma, Solid Tumors,

Location: Westwood KS, Detroit MI, Toronto, Baltimore MD,

Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06915753

Phase1, Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

for

Androgen Axis Suppression, Prostatectomy, Prostate Cancer

Location: Kansas City KS, Chicago IL, Houston TX, Gilbert AZ,

Sponsor: M.D. Anderson Cancer Center

Sex: Male

Age: 18+

Code: NCT06274047

Phase3, Recruiting

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for

Crohn's Disease

Location: Kansas City KS, Kansas City MO, Liberty MO, Topeka KS,

Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06045754

Recruiting

Blue Light Cystoscopy With Cysview® Registry

for

Bladder Cancer

Location: Kansas City KS, Minneapolis MN, Chicago IL, Dallas TX,

Sponsor: Photocure

Sex: All

Age: 18+

Code: NCT02660645

Recruiting

A Study of IBI363 in Subjects with Advanced Solid Malignancies

for

Melanoma, Non-small Cell Lung Cancer, Colorectal Cancer,

Location: Fairway KS, Houston TX, Dearborn MI, Troy MI, Ocala FL,

Sponsor: Innovent Biologics (Suzhou) Co. Ltd.

Sex: All

Age: 18+

Code: NCT06281678

Phase2, Recruiting

Stroke Thrombectomy and Aneurysm Registry

for

Stroke, Thromboses, Intracranial, Aneurysm, Brain

Location: Kansas City KS, St Louis MO, Iowa City IA,

Sponsor: Medical University of South Carolina

Sex: All

Age: 1 - 70+

Code: NCT04994756

Recruiting

Clinical Procedures to Support Research in ALS

for

Amyotrophic Lateral Sclerosis, ALS-Frontotemporal Dementia,

Location: Kansas City KS, Minneapolis MN, San Antonio TX,

Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT03489278

Recruiting

Trial-Ready Cohort-Down Syndrome (TRC-DS)

for

Down Syndrome, Alzheimer Disease, Dementia

Location: Kansas City KS, St Louis MO, Madison WI,

Sponsor: University of Southern California

Sex: All

Age: 25 - 55

Code: NCT04165109

Recruiting

Opioid-Free Pain Treatment in Trauma Patients

for

Femoral Neck Fractures, Intertrochanteric Fractures,

Location: Kansas City KS

Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT06078371

Recruiting

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

for

Type 1 Diabetes Mellitus With Hypoglycemia

Location: Kansas City KS, Omaha NE, Little Rock AR, Dallas TX,

Sponsor: Zucara Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT05762107

Phase2, Recruiting

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

for

Clostridium Difficile, Clostridium Difficile Infections,

Location: Kansas City KS, Weldon Spring MO, St Louis MO,

Sponsor: Vedanta Biosciences, Inc.

Sex: All

Age: 12+

Code: NCT06237452

Phase3, Recruiting

A Study of ASP3082 in Adults With Advanced Solid Tumors

for

Solid Tumor

Location: Westwood KS, St Louis MO, Madison WI, Nashville TN,

Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT05382559

Phase1, Recruiting

Paid Clinical Trials Olathe

Filter results

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

To Develop a Walking Exercise Program for Non-ambulatory Stroke Survivors

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

Interested in new trials?

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Mitigating the Pro-inflammatory Phenotype of Obesity

Abatacept in Immune Checkpoint Inhibitor Myocarditis

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Blue Light Cystoscopy With Cysview® Registry

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Stroke Thrombectomy and Aneurysm Registry

Clinical Procedures to Support Research in ALS

Trial-Ready Cohort-Down Syndrome (TRC-DS)

Opioid-Free Pain Treatment in Trauma Patients

A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

A Study of ASP3082 in Adults With Advanced Solid Tumors